Healthy subjects
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Aged between 20 and 50 years old at consent. (2) Fasting plasma glucose 70-126mg/dl (3) Subjects whose body mass index (BMI) is under 30kg/m2 (4) Subjects who understand the study procedures and agree to participate in the study by giving informed consent prior to the study.
Exclusion criteria
Exclusion criteria: 1) Subjects who have history of malignant diseases. 2) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, organ). 3) Subjects who have previous medical history of drug and/or food allergy. 4) Subjects who have infectious diseases. 5) Subjects who have continuous intake of medicine and/or health food for carbohydrate metabolism 6) Subjects who donated over 200 mL blood within the last one month, and/or over 400 mL blood within the last three month. 7) Subjects with impaired glucose tolerance. 8) Subjects who is menstruating in this clinical test. 9) Females who are pregnant or lactating, and who could become pregnant or lactating during test period. 10) Subjects who plan to participate in other clinical tests. 11) Subjects who are not eligible for this study for some medical reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycemic index(GI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Postprandial blood glucose level, Postprandial maximum blood glucose level, Incremental blood glucose area under the curve GI; Subjects with fasting plasma glucose <100 mg/dL, and =>100 mg/dL, respectively. | — |
Countries
Japan
Contacts
CPCC Company Limited Plan Sales Department